Annual Cash & Cash Equivalents
$142.09 M
-$52.30 M-26.90%
31 December 2023
Summary:
Barinthus Biotherapeutics annual cash & cash equivalents is currently $142.09 million, with the most recent change of -$52.30 million (-26.90%) on 31 December 2023. During the last 3 years, it has risen by +$98.82 million (+228.41%). BRNS annual cash & cash equivalents is now -33.62% below its all-time high of $214.05 million, reached on 31 December 2021.BRNS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$106.10 M
-$11.67 M-9.91%
30 September 2024
Summary:
Barinthus Biotherapeutics quarterly cash and cash equivalents is currently $106.10 million, with the most recent change of -$11.67 million (-9.91%) on 30 September 2024. Over the past year, it has dropped by -$54.21 million (-33.81%). BRNS quarterly cash and cash equivalents is now -56.45% below its all-time high of $243.62 million, reached on 01 June 2021.BRNS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BRNS Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.9% | -33.8% |
| 3 y3 years | +228.4% | -54.6% |
| 5 y5 years | - | - |
BRNS Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -33.6% | +228.4% | -54.6% | at low |
| 5 y | 5 years | -33.6% | +1142.9% | -56.5% | +145.2% |
| alltime | all time | -33.6% | +1142.9% | -56.5% | +145.2% |
Barinthus Biotherapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $106.10 M(-9.9%) |
| June 2024 | - | $117.77 M(-9.4%) |
| Mar 2024 | - | $129.97 M(-8.5%) |
| Dec 2023 | $142.09 M(-26.9%) | $142.09 M(-11.4%) |
| Sept 2023 | - | $160.31 M(-7.4%) |
| June 2023 | - | $173.03 M(-9.6%) |
| Mar 2023 | - | $191.33 M(-1.6%) |
| Dec 2022 | $194.38 M | $194.38 M(-2.9%) |
| Sept 2022 | - | $200.10 M(+4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $192.33 M(-4.1%) |
| Mar 2022 | - | $200.60 M(-6.3%) |
| Dec 2021 | $214.05 M(+394.7%) | - |
| Dec 2021 | - | $214.05 M(-8.5%) |
| Sept 2021 | - | $233.87 M(-4.0%) |
| June 2021 | - | $243.62 M(+56.2%) |
| Mar 2021 | - | $155.94 M(+260.4%) |
| Dec 2020 | $43.27 M(+278.5%) | $43.27 M |
| Dec 2019 | $11.43 M | - |
FAQ
- What is Barinthus Biotherapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual cash & cash equivalents year-on-year change?
- What is Barinthus Biotherapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics quarterly cash and cash equivalents year-on-year change?
What is Barinthus Biotherapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of BRNS is $142.09 M
What is the all time high annual cash & cash equivalents for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual cash & cash equivalents is $214.05 M
What is Barinthus Biotherapeutics annual cash & cash equivalents year-on-year change?
Over the past year, BRNS annual cash & cash equivalents has changed by -$52.30 M (-26.90%)
What is Barinthus Biotherapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BRNS is $106.10 M
What is the all time high quarterly cash and cash equivalents for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly cash and cash equivalents is $243.62 M
What is Barinthus Biotherapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, BRNS quarterly cash and cash equivalents has changed by -$54.21 M (-33.81%)